Form 4: NEUROONE MEDICAL TECHNOLOGIES CFO Receives Stock Grant
Insider Transaction (Form 4)
Christopher Volker, Chief Financial Officer of NEUROONE MEDICAL TECHNOLOGIES Corp, received 35,000 shares of common stock on August 28, 2026.
Summary
- Grant/award: acquired 35,000 Option to Purchase Common Stock on August 28, 2026; holds 35,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Christopher Volker — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-28 | Grant/award | Option to Purchase Common Stock | 35,000 | — | — | 35,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-28 | Grant/award (35,000 shares) |
Keywords
insider transaction, Form 4, NMTC, NEUROONE MEDICAL TECHNOLOGIES Corp, neutral, Christopher Volker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.